BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Naguib MJ, Salah S, Abdel Halim SA, Badr-Eldin SM. Investigating the potential of utilizing glycerosomes as a novel vesicular platform for enhancing intranasal delivery of lacidipine. Int J Pharm 2020;582:119302. [PMID: 32276091 DOI: 10.1016/j.ijpharm.2020.119302] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Touitou E, Natsheh H, Boukeileh S, Awad R. Short Onset and Enhanced Analgesia Following Nasal Administration of Non-Controlled Drugs in Nanovesicular Systems. Pharmaceutics 2021;13:978. [PMID: 34203555 DOI: 10.3390/pharmaceutics13070978] [Reference Citation Analysis]
2 Salem HF, Ali AA, Rabea YK, El-Ela FIA, Khallaf RA. Glycerosomal thermosensitive in situ gel of duloxetine HCl as a novel nanoplatform for rectal delivery: in vitro optimization and in vivo appraisal. Drug Deliv Transl Res 2022. [PMID: 35622235 DOI: 10.1007/s13346-022-01172-z] [Reference Citation Analysis]
3 Naguib MJ, Elsayed I, Teaima MH. Simultaneous Optimization of Oral and Transdermal Nanovesicles for Bioavailability Enhancement of Ivabradine Hydrochloride. Int J Nanomedicine 2021;16:2917-31. [PMID: 33911861 DOI: 10.2147/IJN.S299326] [Reference Citation Analysis]
4 Apolinário AC, Hauschke L, Nunes JR, Lopes LB. Lipid nanovesicles for biomedical applications: 'What is in a name'? Prog Lipid Res 2021;82:101096. [PMID: 33831455 DOI: 10.1016/j.plipres.2021.101096] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
5 Sai Chebrolu T, Kumar L, Verma R. Lacidipine: review of analytical methods developed for pharmaceutical dosage forms and biological fluids. Bioanalysis 2021;13:1011-24. [PMID: 34081530 DOI: 10.4155/bio-2021-0024] [Reference Citation Analysis]
6 Naguib MJ, Hassan YR, Abd-Elsalam WH. 3D printed ocusert laden with ultra-fluidic glycerosomes of ganciclovir for the management of ocular cytomegalovirus retinitis. Int J Pharm 2021;607:121010. [PMID: 34391852 DOI: 10.1016/j.ijpharm.2021.121010] [Reference Citation Analysis]
7 Joseph Naguib M, Moustafa Kamel A, Thabet Negmeldin A, Elshafeey AH, Elsayed I. Molecular docking and statistical optimization of taurocholate-stabilized galactose anchored bilosomes for the enhancement of sofosbuvir absorption and hepatic relative targeting efficiency. Drug Deliv 2020;27:996-1009. [PMID: 32611266 DOI: 10.1080/10717544.2020.1787557] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
8 Goel H, Kalra V, Verma SK, Dubey SK, Tiwary AK. Convolutions in the rendition of nose to brain therapeutics from bench to bedside: Feats & fallacies. J Control Release 2021;341:782-811. [PMID: 34906605 DOI: 10.1016/j.jconrel.2021.12.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Fahmy UA, Badr-Eldin SM, Ahmed OAA, Aldawsari HM, Tima S, Asfour HZ, Al-Rabia MW, Negm AA, Sultan MH, Madkhali OAA, Alhakamy NA. Intranasal Niosomal In Situ Gel as a Promising Approach for Enhancing Flibanserin Bioavailability and Brain Delivery: In Vitro Optimization and Ex Vivo/In Vivo Evaluation. Pharmaceutics 2020;12:E485. [PMID: 32471119 DOI: 10.3390/pharmaceutics12060485] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
10 Zhu C, Zhang Y, Wu T, He Z, Guo T, Feng N. Optimizing glycerosome formulations via an orthogonal experimental design to enhance transdermal triptolide delivery. Acta Pharmaceutica 2022;72:135-46. [DOI: 10.2478/acph-2022-0006] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Natsheh H, Touitou E. Phospholipid Vesicles for Dermal/Transdermal and Nasal Administration of Active Molecules: The Effect of Surfactants and Alcohols on the Fluidity of Their Lipid Bilayers and Penetration Enhancement Properties. Molecules 2020;25:E2959. [PMID: 32605117 DOI: 10.3390/molecules25132959] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
12 Naguib MJ, Makhlouf AIA. Scalable flibanserin nanocrystal-based novel sublingual platform for female hypoactive sexual desire disorder: engineering, optimization adopting the desirability function approach and in vivo pharmacokinetic study. Drug Deliv 2021;28:1301-11. [PMID: 34176378 DOI: 10.1080/10717544.2021.1938755] [Reference Citation Analysis]